Established in 1983, Emcure
was born out of the vision to create a healthcare company that would address the vast healthcare needs. Our commitment and drive have propelled our growth from a single manufacturing facility during the genesis, to a range of world class manufacturing facilities spread across API, formulations and biotechnology.
What began with a single manufacturing facility at Pune, has today rapidly grown into a set of world class manufacturing facilities and one of the top Indian pharmaceutical corporates in the domestic industry.
Headquartered in Pune, India, Emcure is today a vertically integrated pharmaceutical company with infrastructure, skills and resources that are at par with the best in the world. Our strengths span research to the manufacturing of APIs, Formulations and Biotechnology.
The Company has carved a niche for itself as a preferred outsourcing partner for some of the largest MNCs both in India and global markets.
Emcure also researches, manufactures and markets formulations under its own brands in the domestic market and exports its own formulations to Asia, Africa, CIS, Europe, Latin America and the Middle East.
In 2006, it received US FDA approval for its solid dosages facility at Hinjwadi, Pune. The plant manufactures solid oral formulations for the international regulated markets. With this approval, the facility has accreditation from US FDA, UK MHRA, WHO Geneva and MCC South Africa.
Today, the Emcure brand stands for quality, competitiveness and transparency. These values have stood us in good stead to carve our image in the industry and build long-term sustainable relationships with our partners.
Emcure is building its pipeline of Chiral and conventional APIs and is emerging as a strong player in the biotechnology front.
Emcure is also very active in dealing with HIV/AIDS concern through its "Let's fight AIDS together" initiative and supplies Antiretroviral drugs to Africa, Asia Pacific and CIS. We took another significant step towards fulfilling our corporate social responsibility by starting 'Taal'
, a pharmacy for HIV/AIDS.